Table 2.
Pre-treatment and average on-treatment hematologic characteristics for the cohort (n = 257).
| Variable | Pre-treatment |
Average on-treatment |
||
|---|---|---|---|---|
| n | % | n | % | |
| Hemoglobin (g/L) | ||||
| Median | 128 | 118 | ||
| Range | 46–164 | 88–152 | ||
| ≤115 | 74 | 28.8 | 109 | 42.4 |
| >115 | 181 | 70.4 | 145 | 56.4 |
| Missing | 2 | 0.8 | 3 | 1.2 |
| WBC (109/L) | ||||
| Median | 8.3 | 6.0 | ||
| Range | 2.9–24.7 | 2.1–17.5 | ||
| ≤10 | 175 | 68.1 | 230 | 89.5 |
| >10 | 69 | 26.9 | 14 | 5.5 |
| Missing | 13 | 5.1 | 13 | 5.1 |
| NLR | ||||
| Median | 3.2 | |||
| Range | 1.04–31.8 | |||
| ≤5 | 191 | 74.3 | ||
| >5 | 52 | 20.2 | ||
| Missing | 14 | 5.5 | ||
| Platelets (109/L) | ||||
| Median | 321.5 | |||
| Range | 115–1069 | |||
| ≤400 | 181 | 70.4 | ||
| >400 | 63 | 24.5 | ||
| Missing | 13 | 5.1 | ||
WBC = white blood cell; NLR = neutrophil-to-lymphocyte ratio.